GSK3B and acute kidney injury: To determine if inhibition of GSK3β possibly represents a key mechanism conveying the beneficial activity of Tanshinone IIA after AKI, additional mice received Tanshinone IIA therapy in the presence of daily treatment with vehicle or sodium nitroprusside, a GSK3β activator48, starting 1 day or 5 days after folic acid injury.